MeiraGTx Limited logo

MeiraGTx Limited

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”MGTX” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://meiragtx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENASDAQ: MGTX
Address
92 Britannia WalkLondon N1 7NQUK,
London
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/meiragtx” connections=”true” suffix=””]